Article

jdsupra.com on 2019-10-04 02:44

Clarifying Clinical Decision Support: FDA Overhauls Guidance To Focus On Risk

On 27 September 2019 the U.S. Food and Drug Administration (FDA or the agency) released the draft guidance entitled "Clinical Decision Support ...

Related news

FDA Overhauls its Draft Guidance on Clinical Decision Support (“CDS”) Software jdsupra.com
California , United States , Switzerland
Updated FDA COVID-19 Guidance for Conduct of Clinical Trials jdsupra.com
California , United States , Switzerland
FDA Issues Guidance on Clinical Trials During COVID-19 Pandemic jdsupra.com
California , United States , Switzerland
Crackdown coming? Draft guidance suggests FDA is looking more closely at clinical trial disclosures jdsupra.com
California , United States , Switzerland
FDA Draft Guidance Regarding Inclusion of Pregnant Women in Clinical Trials jdsupra.com
California , United States , Switzerland
FDA Updates its Guidance on Conducting Clinical Trials During COVID-19 Public Health Emergency jdsupra.com
California , United States , Switzerland
FDA issues guidance on use of EHR data in clinical research jdsupra.com
California , United States , Switzerland
FDA details recommendations for live case presentations during medical device clinical trials in final guidance jdsupra.com
California , United States , Switzerland
FDA Releases Guidance on How Recent Changes to the Common Rule May Impact FDA-Regulated Clinical Trials jdsupra.com
California , United States , Switzerland
FDA Issues Guidance on Clinical Trials During the COVID-19 Pandemic jdsupra.com
California , United States , Switzerland
FDA Issues Final Guidance on Conduct of Clinical Trials of Medical Products During COVID-19 Pandemic jdsupra.com
California , United States , Switzerland
FDA Guidance on Conducting Clinical Trials During the COVID-19 Pandemic jdsupra.com
California , United States , Switzerland
A Very Fine Line — Split Decision: FDA Issues Draft Guidance on Clinical Decision Support Software jdsupra.com
California , United States , Switzerland
FDA Issues Guidance for Ongoing Clinical Trials During COVID-19 Pandemic jdsupra.com
California , United States , Switzerland
FDA Issues Guidance for Clinical Trial Sponsors and Investigators Regarding Impact of COVID-19 on Clinical Trials jdsupra.com
California , United States , Switzerland
FDA Issues Additional Guidance on the Conduct of Clinical Trials During the COVID-19 Pandemic jdsupra.com
California , United States , Switzerland
New FDA Draft Guidance Encourages Industry Focus on Improving Clinical Trial Diversity jdsupra.com
Capitol Hill , United States
House Appropriations Committee Cautions FDA To Focus on Public Health and Preserve Clinical Study Incentives As It Examines CBD Pathways jdsupra.com
California , United States , Switzerland , Oregon
New York State Releases Clarifying Guidance on Student Immunization Law jdsupra.com
California , United States , Switzerland
Five federal regulators issue statement clarifying role of supervisory guidance jdsupra.com
California , United States , Switzerland